Danaher (NYSE:DHR) issued an update on its third quarter 2019 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $1.12-1.15 for the period, compared to the Thomson Reuters consensus estimate of $1.16. Danaher also updated its FY 2019 guidance to $4.75-4.80 EPS.
Shares of NYSE:DHR opened at $141.61 on Friday. The company’s fifty day moving average is $140.27. The stock has a market capitalization of $101.38 billion, a PE ratio of 31.33, a price-to-earnings-growth ratio of 2.56 and a beta of 0.96. Danaher has a 12-month low of $94.59 and a 12-month high of $145.50. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, July 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.15 by $0.04. The business had revenue of $5.16 billion during the quarter, compared to analysts’ expectations of $5.09 billion. Danaher had a return on equity of 11.73% and a net margin of 12.22%. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.15 earnings per share. Sell-side analysts predict that Danaher will post 4.77 EPS for the current fiscal year.
A number of research firms have commented on DHR. Zacks Investment Research lowered GALP ENERGIA SG/ADR from a hold rating to a sell rating in a report on Monday, May 6th. Needham & Company LLC reissued a buy rating and issued a $155.00 target price (up previously from $142.00) on shares of Danaher in a report on Friday. Janney Montgomery Scott lifted their target price on Danaher from $136.00 to $174.00 and gave the stock a buy rating in a report on Wednesday, April 17th. Piper Jaffray Companies raised Post from a neutral rating to an overweight rating and lifted their target price for the stock from $106.00 to $130.00 in a report on Thursday. Finally, Wolfe Research began coverage on Waters in a report on Thursday, May 30th. They issued an underperform rating for the company. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Danaher presently has an average rating of Buy and an average price target of $139.08.
In other news, Chairman Mitchell P. Rales acquired 1,900 shares of the business’s stock in a transaction that occurred on Friday, May 10th. The stock was bought at an average price of $130.78 per share, with a total value of $248,482.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Alan G. Spoon sold 1,913 shares of Danaher stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $129.52, for a total value of $247,771.76. Following the completion of the sale, the director now directly owns 86,863 shares of the company’s stock, valued at approximately $11,250,495.76. The disclosure for this sale can be found here. Insiders sold 453,448 shares of company stock valued at $59,724,640 in the last ninety days. 11.40% of the stock is currently owned by corporate insiders.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: How to interpret a stock’s beta number
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.